Non-toxic plant metabolites regulate Staphylococcus viability and biofilm formation: a natural therapeutic strategy useful in the treatment and prevention of skin infections

Biofouling

Volumn 30, Issue 10, 2014, Pages 1175-1182

  Moran A ^a   Gutierrez S ^a   Martinez Blanco H ^a   Ferrero, M A ^a   Monteagudo Mera, A ^a   Rodriguez Aparicio L B ^a  

^a UNIVERSITY OF LEÓN   (Spain)

Author keywords

antimicrobial; biofilm; non toxic plant metabolites; skin infection; Staphylococcus

Indexed keywords

BIOFILM; CHEMICAL ELEMENT; DISEASE TREATMENT; GROWTH RATE; INFECTIOUS DISEASE; METABOLITE; MICROBIAL COMMUNITY; PLANT COMMUNITY; SKIN;

STAPHYLOCOCCUS;

ANTIINFECTIVE AGENT; GENISTEIN; HYDROXYBENZOIC ACID DERIVATIVE; PLANT EXTRACT; PROTOCATECHUIC ACID; RESVERATROL; STILBENE DERIVATIVE;

BIOFILM; CHEMISTRY; CRANBERRY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; MICROBIAL SENSITIVITY TEST; SKIN DISEASES, BACTERIAL; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

ANTI-BACTERIAL AGENTS; BIOFILMS; GENISTEIN; HYDROXYBENZOATES; MICROBIAL SENSITIVITY TESTS; PLANT EXTRACTS; SKIN DISEASES, BACTERIAL; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STILBENES; VACCINIUM MACROCARPON;

EID: 84915770383     PISSN: 08927014     EISSN: 10292454     Source Type: Journal    
DOI: 10.1080/08927014.2014.976207     Document Type: Article

References (51)

1. Ali S, Khan A, Ahmed I, Musaddiq M, Ahmed K, Polasa H, Rao L, Habibullah C, Sechi L, Ahmed N. 2005. Antimicrobial activities of eugenol and cinnamaldehyde against the human gastric pathogen Helicobacter pylori. Ann Clin Microbiol Antimicrob. 4:20–27.10.1186/1476-0711-4-20
2. Borges A, Saavedra MJ, Simões M. 2012. The activity of ferulic and gallic acids in biofilm prevention and control of pathogenic bacteria. Biofouling. 28:755–767.10.1080/08927014.2012.706751
3. Botelho MA, Nogueira NAP, Bastos GM, Fonseca SGC, Lemos TLG, Matos FJA, Montenegro D, Heukelbach J, Rao VS, Brito GAC. 2007. Antimicrobial activity of the essential oil from Lippia sidoides, carvacrol and thymol against oral pathogens. Braz J Med Biol Res. 40:349–356.10.1590/S0100-879X2007000300010
4. Cerca N, Martins S, Cerca F, Jefferson KK, Pier GB, Oliveira R, Azeredo J. 2005. Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother. 56:331–336.10.1093/jac/dki217
5. Chambers HF, DeLeo FR. 2009. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 7:629–641.10.1038/nrmicro2200
6. Chong KP, Rossall S, Atong M. 2009. In vitro antimicrobial activity and fungitoxicity of syringic acid, caffeic acid and 4-hydroxybenzoic acid against Ganoderma boninense. J Agric Sci. 1:15–20.
7. Christensen GJM, Brüggemann H. 2013. Bacterial skin commensals and their role as host guardians. Benef Microbes. 5:201–215.
8. Coenye T, Brackman G, Rigole P, De Witte E, Honraet K, Rossel B, Nelis HJ. 2012. Eradication of Propionibacterium acnes biofilms by plant extracts and putative identification of icariin, resveratrol and salidroside as active compounds. Phytomed. Int J Phytother Phytopharm. 19:409–412.10.1016/j.phymed.2011.10.005
9. Cowan MM. 1999. Plant products as antimicrobial agents. Clin Microbiol Rev. 12:564–582.
10. DeLeo FR, Chambers HF. 2009. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J Clin Invest. 119:2464–2474.10.1172/JCI38226
11. Drea WF. 1944. Antibacterial effects of various organic substances upon the H37 strain of human tubercle bacilli in a simple synthetic medium. J Bacteriol. 48:547–553.
12. Fernández MA, García MD, Sáenz MT. 1996. Antibacterial activity of the phenolic acids fractions of Scrophularia frutescens and Scrophularia sambucifolia. J Ethnopharmacol. 53:11–14.10.1016/0378-8741(96)01419-5
13. Friedman B-C, Goldman RD. 2011. Anti-staphylococcal treatment in dermatitis. Can Fam Physician. 57:669–671.
14. Gomes F, Teixeira P, Oliveira R. 2013. Mini-review: Staphylococcus epidermidis as the most frequent cause of nosocomial infections: old and new fighting strategies. Biofouling. 30:131–141.
15. Grice EA, Segre JA. 2011. The skin microbiome. Nat Rev Microbiol. 9:244–253.10.1038/nrmicro2537
16. Guay DRP. 2009. Cranberry and urinary tract infections. Drugs. 69:775–807.10.2165/00003495-200969070-00002
17. Gyawali R, Ibrahim SA. 2012. Impact of plant derivatives on the growth of foodborne pathogens and the functionality of probiotics. Appl Microbiol Biotechnol. 95:29–45.10.1007/s00253-012-4117-x
18. Halcón L, Milkus K. 2004. Staphylococcus aureus and wounds: a review of tea tree oil as a promising antimicrobial. Am J Infect Control. 32:402–408.10.1016/j.ajic.2003.12.008
19. Himejima M, Nihei K, Kubo I. 2004. Hydroquinone, a control agent of agglutination and adherence of Streptococcus mutans induced by sucrose. Bioorg Med Chem. 12:921–925.10.1016/j.bmc.2003.12.020
20. Hong H, Landauer MR, Foriska MA, Ledney GD. 2006. Antibacterial activity of the soy isoflavone genistein. J Basic Microbiol. 46:329–335.10.1002/(ISSN)1521-4028
21. Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. 2009. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics. 123:e808–e814.10.1542/peds.2008-2217
22. Iwase T, Uehara Y, Shinji H, Tajima A, Seo H, Takada K, Agata T, Mizunoe Y. 2010. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature. 465:346–349.10.1038/nature09074
23. Kamatou GP, Vermaak I, Viljoen AM. 2012. Eugenol – from the remote Maluku Islands to the international market place: a review of a remarkable and versatile molecule. Molecules. 17:6953–6981.10.3390/molecules17066953
24. Karatan E, Watnick P. 2009. Signal, regulatory networks, and materials that build and break bacterial biofilms. Microbiol Mol Biol Rev. 73:310–347.10.1128/MMBR.00041-08
25. Kiedrowski MR, Horswill AR. 2011. New approaches for treating staphylococcal biofilm infections. Ann N Y Acad Sci. 1241:104–121.10.1111/j.1749-6632.2011.06281.x
26. Kubota H, Senda S, Nomura N, Tokuda H, Uchiyama H. 2008. Biofilm formation by lactic acid bacteria and resistance to environmental stress. J Biosci Bioeng. 106:381–386.10.1263/jbb.106.381
27. LaPlante KL, Sarkisian SA, Woodmansee S, Rowley DC, Seeram NP. 2012. Effects of cranberry extracts on growth and biofilm production of Escherichia coli and Staphylococcus species. Phytother Res. 26:1371–1374.10.1002/ptr.v26.9
28. Lee J-H, Cho HS, Joo SW, Chandra Regmi S, Kim J-A, Ryu C-M, Ryu SY, Cho MH, Lee J. 2013. Diverse plant extracts and trans-resveratrol inhibit biofilm formation and swarming of Escherichia coli O157:H7. Biofouling. 29:1189–1203.10.1080/08927014.2013.832223
29. Levy SB. 1998. The challenge of antibiotic resistance. Sci Am. 278:46–53.10.1038/scientificamerican0398-46
30. Matsunaga T, Nakahara A, Minnatul KM, Noiri Y, Ebisu S, Kato A, Azakami H. 2010. The inhibitory effects of catechins on biofilm formation by the periodontopathogenic bacterium, Eikenella corrodens. Biosci Biotech Bioch. 74:2445–2450.10.1271/bbb.100499
31. Monteagudo-Mera A, Rodríguez-Aparicio LB, Rúa J, Martínez-Blanco H, Navasa N, García-Armesto MR, Ferrero MA. 2012. In vitro evaluation of physiological probiotic properties of different lactic acid bacteria strains on dairy and human origin. J Funct Foods. 4:531–541.10.1016/j.jff.2012.02.014
32. Murillo N, Raoult D. 2013. Skin microbiota: overview and role in the skin diseases acne vulgaris and rosacea. Future Microbiol. 8:209–222.10.2217/fmb.12.141
33. NCCLS (National Committee for Clinical Laboratory Standards). 2002. Performance standards for antimicrobial susceptibility testing. 12th informational supplement. Approved standard M100-S12. National Committee for Clinical Laboratory Standards; Wayne, PA.
34. Otto M. 2009. Staphylococcus epidermidis – the “accidental” pathogen. Nat Rev Microbiol. 7:555–567.10.1038/nrmicro2182
35. Otto M. 2013. Staphylococcal infections: mechanism of biofilm maturation and detachment as critical determinants of pathogenicity. Annu Rev Med. 64:1–14.
36. Parkar SG, Stevenson DE, Skinner MA. 2008. The potential influence of fruit polyphenols on colonic microflora and human gut health. International J Food Microbiol. 124:295–298.10.1016/j.ijfoodmicro.2008.03.017
37. Paulo L, Ferreira S, Gallardo E, Queiroz JA, Domingues F. 2010. Antimicrobial activity and effects of resveratrol on human pathogenic bacteria. World J Microbiol Biotechnol. 26:1533–1538.10.1007/s11274-010-0325-7
38. Puupponen-Pimiä R, Nohynek L, Hartmann-Schmidlin S, Kähkönen M, Heinonen M, Määttä-Riihinen K, Oksman-Caldentey K-M. 2005. Berry phenolics selectively inhibit the growth of intestinal pathogens. J App Microbiol. 98:991–1000.10.1111/jam.2005.98.issue-4
39. Rafsanjany N, Lechtenberg M, Petereit F, Hensel A. 2013. Antiadhesion as a functional concept for protection against uropathogenic Escherichia coli: in vitro studies with traditionally used plants with antiadhesive activity against uropathogenic Escherichia coli. J Ethnopharmacol. 145:591–597.10.1016/j.jep.2012.11.035
40. Rauha J-P, Remes S, Heinonen M, Hopia A, Kähkönen M, Kujala T, Pihlaja K, Vuorela H, Vuorela P. 2000. Antimicrobial effects of Finnish plant extracts containing flavonoids and other phenolic compounds. Int J Food Microbiol. 56:3–12.10.1016/S0168-1605(00)00218-X
41. Rogers KL, Fey PD, Rupp ME. 2009. Coagulase-negative staphylococcal infections. Infect Dis Clin North Am. 23:73–98.10.1016/j.idc.2008.10.001
42. Sato M, Tanaka H, Yamaguchi R, Kato K, Etoh H. 2004. Synergistic effects of mupirocin and an isoflavonone isolated form Erythirina variegate on growth and recovery of methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents. 24:43–48.
43. Schmidt DR, Sobota AE. 1987. An examination of the anti-adherence activity of cranberry juice on urinary and nonurinary bacterial isolates. Microbios. 55:173–181.
44. Shimamura T, Zhao W-H, Hu Z-Q. 2007. Mechanism of action and potential for use of tea catechin as an antiinfective agent. Anti-Infect Agents Med Chem Former Curr Med Chem – Anti-Infect Agents. 6:57–62.
45. Toda M, Okubo S, Ikigai H, Suzuki T, Suzuki Y, Hara Y, Shimamura T. 1991. The protective activity of tea catechins against experimental infection by Vibrio cholerae O1. Microbiol Immunol. 36:999–1001.
46. Ultee A, Kets EPW, Smid EJ. 1999. Mechanisms of action of carvacrol on the food-borne pathogen Bacillus cereus. App Environm Microbiol. 65:4606–4610.
47. Upadhyay A, Upadhyaya I, Kollanoor-Johny A, Venkitanarayanan K. 2013. Antibiofilm effect of plant derived antimicrobials on Listeria monocytogenes. Food Microbiol. 36:79–89.10.1016/j.fm.2013.04.010
48. Venkitanarayanan K, Kollanoor-Johny A, Darre MJ, Donoghue AM, Donoghue DJ. 2013. Use of plant-derived antimicrobials for improving the safety of poultry products. Poult Sci. 92:493–501.10.3382/ps.2012-02764
49. Williams RE, Gibson AG, Aitchison TC, Lever R, Mackie RM. 1990. Assessment of a contact-plate sampling technique and subsequent quantitative bacterial studies in atopic dermatitis. Br J Dermatol. 123:493–501.
50. Wolf R, Wolf D. 2012. Abnormal epidermal barrier in the pathogenesis of atopic dermatitis. Clin Dermatol. 30:329–334.10.1016/j.clindermatol.2011.08.023
51. Wright GD. 2010. Antibiotic resistance in the environment: a link to the clinic? Curr Opin Microbiol. 13:589–594.10.1016/j.mib.2010.08.005